195 related articles for article (PubMed ID: 6628518)
1. Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.
Nuotto E; Gordin A; Paasonen MK; Metsä-Ketelä T; Lamminsivu U
Eur J Clin Pharmacol; 1983; 25(3):313-7. PubMed ID: 6628518
[TBL] [Abstract][Full Text] [Related]
2. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man.
Küster LJ; Frölich JC
Prostaglandins; 1986 Sep; 32(3):415-23. PubMed ID: 3097760
[TBL] [Abstract][Full Text] [Related]
3. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
Bode-Böger SM; Böger RH; Schubert M; Frölich JC
Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
[TBL] [Abstract][Full Text] [Related]
4. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Lorenz R; Siess W; Weber PC
Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
[TBL] [Abstract][Full Text] [Related]
5. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
Gurbel PA; Bliden KP; Tantry US
J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
[TBL] [Abstract][Full Text] [Related]
6. Effect of acetylsalicylic acid on platelet aggregation and thromboxane B2 production in flowing aortic blood in the rat studied with a filter loop technique.
Martin JF; Suggett AJ; Jones PB; Leach E
Thromb Res; 1982 Aug; 27(3):251-9. PubMed ID: 6814004
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of inhibitory effects of low-dose ASA on thromboxane production and platelet aggregation in ischemic stroke patients.
Lee TK; Ng SK; Huang ZS; Chen YC
J Formos Med Assoc; 1992 Sep; 91(9):891-7. PubMed ID: 1363390
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
9. Long-term ultra-low-dose aspirin therapy and platelet function.
Chetty N; Atkinson PM; Bradlow BA
S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid.
Rosenkranz B; Frölich JC
Prostaglandins Leukot Med; 1985 Sep; 19(3):289-300. PubMed ID: 3864170
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
Patrick J; Dillaha L; Armas D; Sessa WC
Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
[TBL] [Abstract][Full Text] [Related]
12. Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low-dose aspirin (ASA) in healthy volunteers.
Sinzinger H; Virgolini I; Peskar BA
Thromb Res; 1989 Feb; 53(3):261-9. PubMed ID: 2497545
[TBL] [Abstract][Full Text] [Related]
13. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin.
Louden KA; Broughton Pipkin F; Heptinstall S; Fox SC; Tuohy P; O'Callaghan C; Mitchell JR; Symonds EM
Br J Obstet Gynaecol; 1994 Mar; 101(3):203-8. PubMed ID: 8193093
[TBL] [Abstract][Full Text] [Related]
14. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
15. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
[TBL] [Abstract][Full Text] [Related]
16. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
17. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
18. The effect of acetylsalicylic acid in 3 different formulations on in vitro and in vivo platelet function tests. An experimental study on healthy male volunteers.
Kutti J; Safai-Kutti S; Sigvaldason A; Edgar B; Lundborg P
Scand J Haematol; 1984 Apr; 32(4):379-84. PubMed ID: 6719042
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid.
Thorngren M; Shafi S; Born GV
Lancet; 1983 May; 1(8333):1075-8. PubMed ID: 6133107
[TBL] [Abstract][Full Text] [Related]
20. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
Ylikorkala O; Puolakka J; Viinikka L
Am J Obstet Gynecol; 1982 Mar; 142(5):573-6. PubMed ID: 7036746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
